Exelixis Stock Ten Year Return
| EXEL Stock | USD 33.97 0.03 0.09% |
Exelixis fundamentals help investors to digest information that contributes to Exelixis' financial success or failures. It also enables traders to predict the movement of Exelixis Stock. The fundamental analysis module provides a way to measure Exelixis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Exelixis stock.
Exelixis | Ten Year Return |
Exelixis Company Ten Year Return Analysis
Exelixis' Ten Year Return shows the total annualized return generated from holding a fund for the last 10 years and represents fund's capital appreciation, including dividends losses and capital gains distributions. This return indicator is considered by many investors to be the ultimate measures of fund performance and can reflect the overall performance of the market or market segment it invests in.
More About Ten Year Return | All Equity Analysis
Ten Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Exelixis Ten Year Return Driver Correlations
Understanding the fundamental principles of building solid financial models for Exelixis is extremely important. It helps to project a fair market value of Exelixis Stock properly, considering its historical fundamentals such as Ten Year Return. Since Exelixis' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Exelixis' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Exelixis' interrelated accounts and indicators.
Click cells to compare fundamentals
Although Ten Year Fund Return indicator can give a sense of overall fund long-term potential, it is recommended to compare funds performances against other similar funds or market benchmarks for the same 10-year interval.
| Competition |
Exelixis Return On Tangible Assets
Return On Tangible Assets |
|
Based on the latest financial disclosure, Exelixis has a Ten Year Return of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Exelixis Ten Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Exelixis' direct or indirect competition against its Ten Year Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Exelixis could also be used in its relative valuation, which is a method of valuing Exelixis by comparing valuation metrics of similar companies.Exelixis is currently under evaluation in ten year return category among its peers.
Exelixis ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Exelixis' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Exelixis' managers, analysts, and investors.Environmental | Governance | Social |
Exelixis Fundamentals
| Return On Equity | 0.2 | ||||
| Return On Asset | 0.13 | ||||
| Profit Margin | 0.22 % | ||||
| Operating Margin | 0.35 % | ||||
| Current Valuation | 8.71 B | ||||
| Shares Outstanding | 285.58 M | ||||
| Shares Owned By Insiders | 1.53 % | ||||
| Shares Owned By Institutions | 89.25 % | ||||
| Number Of Shares Shorted | 7.33 M | ||||
| Price To Earning | 48.17 X | ||||
| Price To Book | 4.26 X | ||||
| Price To Sales | 4.66 X | ||||
| Revenue | 1.83 B | ||||
| Gross Profit | 1.55 B | ||||
| EBITDA | 196.6 M | ||||
| Net Income | 207.76 M | ||||
| Cash And Equivalents | 1.53 B | ||||
| Cash Per Share | 4.77 X | ||||
| Total Debt | 189.94 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 6.08 X | ||||
| Book Value Per Share | 7.96 X | ||||
| Cash Flow From Operations | 333.32 M | ||||
| Short Ratio | 4.01 X | ||||
| Earnings Per Share | 1.55 X | ||||
| Price To Earnings To Growth | 2.27 X | ||||
| Target Price | 33.56 | ||||
| Number Of Employees | 1.31 K | ||||
| Beta | 0.51 | ||||
| Market Capitalization | 9.7 B | ||||
| Total Asset | 2.94 B | ||||
| Retained Earnings | (173.35 M) | ||||
| Working Capital | 923.68 M | ||||
| Current Asset | 178.66 M | ||||
| Current Liabilities | 52.25 M | ||||
| Net Asset | 2.94 B |
About Exelixis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Exelixis's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Exelixis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Exelixis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Exelixis Piotroski F Score and Exelixis Altman Z Score analysis. For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exelixis. If investors know Exelixis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exelixis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 121.699 | Earnings Share 1.55 | Revenue Per Share | Quarterly Revenue Growth 0.143 | Return On Assets |
The market value of Exelixis is measured differently than its book value, which is the value of Exelixis that is recorded on the company's balance sheet. Investors also form their own opinion of Exelixis' value that differs from its market value or its book value, called intrinsic value, which is Exelixis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exelixis' market value can be influenced by many factors that don't directly affect Exelixis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Exelixis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Exelixis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exelixis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.